In agreement with cell‐based experiments, the immunofluorescence staining of the LLC‐allograft tumor section revealed a substantial decrease in TTF1 and CD206 expression levels, implying the effective elimination of LLC cells and TAMs (Figure 8A). The gene discussed is MRC1; the disease is neoplasm.